SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-16-517511
Filing Date
2016-03-25
Accepted
2016-03-25 06:12:08
Documents
5
Effectiveness Date
2016-03-25

Document Format Files

Seq Description Document Type Size
1 DEFA14A d137783ddefa14a.htm DEFA14A 42393
2 GRAPHIC g137783ima2.jpg GRAPHIC 2939
3 GRAPHIC g137783ima3.jpg GRAPHIC 11005
4 GRAPHIC g137783ima4.jpg GRAPHIC 2484
5 GRAPHIC g137783ima5.jpg GRAPHIC 6691
  Complete submission text file 0001193125-16-517511.txt   75904
Mailing Address 887 GREAT NORTHERN WAY SUITE 450 VANCOUVER A1 V5T 4T5
Business Address 887 GREAT NORTHERN WAY SUITE 450 VANCOUVER A1 V5T 4T5 604-629-9223
AQUINOX PHARMACEUTICALS, INC (Filer) CIK: 0001404644 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36327 | Film No.: 161528765
SIC: 2834 Pharmaceutical Preparations